Pharmaceutical & NDI

In Germany it has been a non-prescription pharmacy-only medicine since 2005. From the 1950s until 2005, it was a prescription drug for indications in women with menopausal symptoms and younger women with cycle irregularities, etc.

It has been evaluated by the BfArM (German FDA) 2005:
For the improvement of menopausal-related psychological and neurovegetative symptoms such as:

– Hot flushes/sweats
– sleep disturbances
– depressive moods
– Anxiety

In the US, Canada, Mexico, India, South Africa, South Korea, Australia, New Zealand and other countries it has a notification as New Dietary Ingredient (NDI).

ERr 731® is in and between pharma and food and in further development for the innovative area of personalized health medicine and nutrition science to prevent and treat health conditions such as depression, anxiety … . 

The constituents and metabolites of ERr 731® are plant polyphenoles such as reveratrol, piceatannol  and may have potential influence on lifespan and the aging process.